Arbutus Biopharma Corporation ABUS Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's net debt?
- Arbutus Biopharma Corporation (ABUS) reported net debt of -$23.08M in Q1 2026.
- How has Arbutus Biopharma Corporation's net debt changed year-over-year?
- Arbutus Biopharma Corporation's net debt increased by 35.7% year-over-year, from -$35.89M to -$23.08M.
- What is the long-term trend for Arbutus Biopharma Corporation's net debt?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's net debt has grown at a -18.9% compound annual growth rate (CAGR), from -$49.27M to -$17.26M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.